In tumor development, the combination of PD-1 and its corresponding ligand programmed death-ligand 1 (PD-L1) can lead to cytotoxic T cell exhaustion, which impairs the immune system’s ability to recognize and attack the cancer cells36. The gene discussed is CD274; the disease is cancer.